Hara Yukiko, Sakurai Kenichi, Fujisaki Shigeru, Nagashima Saki, Suzuki Shuhei, Shibata Masahiko, Tomita Ryouichi, Matsumoto Kyoko, Enomoto Katsuhisa, Amano Sadao
Division of Breast and Endocrine Surgery, Dept. of Surgery, Nihon University School of Medicine.
Gan To Kagaku Ryoho. 2011 Nov;38(12):2014-6.
We report a case of non-palpating breast cancer with huge lymph node metastasis. The patient was a 58-year-old woman who had a huge tumor at her right armpit. The tumor was 4 cm in diameter. Aspiration biopsy cytology for the tumor was performed. The diagnosis is Class V. Mammography showed an ill-defined mass at her right breast. Ultrasonography revealed a low echoic mass at the C area of her right breast. A core needle biopsy for the breast tumor led to a diagnosis of an invasive ductal carcinoma positive for estrogen receptor and progesterone receptor, and negative for HER2/neu protein expression. She received 4 cycles of CEF (E: 60 mg/tri-weekly) plus 12 cycles of paclitaxe (l80 mg/weekly). After chemotherapy, she received muscle preserving mastectomy plus axillary lymph nodes dissection. In histopathology, there were no carcinoma cells in resected breast tissue and resected lymph nodes. Therefore, the effect of chemotherapy was diagnosed as a pathological complete response. After operation, she was administered aromatase inhibitor. The patient has been well and remained disease-free during a follow-up period of 6 years.
我们报告一例不可触及的伴有巨大淋巴结转移的乳腺癌病例。患者为一名58岁女性,其右腋窝有一个巨大肿瘤。肿瘤直径为4厘米。对该肿瘤进行了细针穿刺活检细胞学检查。诊断为V级。乳腺钼靶检查显示右乳有一个边界不清的肿块。超声检查显示右乳C区有一个低回声肿块。对乳腺肿瘤进行粗针穿刺活检,诊断为雌激素受体和孕激素受体阳性、HER2/neu蛋白表达阴性的浸润性导管癌。她接受了4个周期的CEF(E:60毫克/每三周一次)加12个周期的紫杉醇(180毫克/每周)治疗。化疗后,她接受了保乳根治术加腋窝淋巴结清扫术。在组织病理学检查中,切除的乳腺组织和切除的淋巴结中均未发现癌细胞。因此,化疗效果被诊断为病理完全缓解。术后,她接受了芳香化酶抑制剂治疗。在6年的随访期内,患者情况良好,无疾病复发。